Risk Stratification and Adjuvant Chemotherapy for High‐Risk Stage <scp>IA</scp> Lung Adenocarcinoma: The Unmet Needs
ACT failed to meet the needs of stage IA patients with histological high-risk features. Further exploration of effective adjuvant target therapies is warranted for this patient subgroup.
Authors
- Haoran Liu (ORCID: https://orcid.org/0009-0006-2257-113X)
- Fang Wen (ORCID: https://orcid.org/0000-0002-3170-8971)
- Bofei Li (ORCID: https://orcid.org/0000-0002-8619-5210)
- Jiaming Wang (ORCID: https://orcid.org/0000-0001-7881-7158)
- Yiyang Wang (ORCID: https://orcid.org/0000-0002-0318-6715)
- Zhitao Gu
- Chen Shen (ORCID: https://orcid.org/0009-0003-7573-0198)
- Feichao Bao
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1111/1759-7714.15521
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Shanghai Hospital Development Center